Lori Anne Kunkel is a director of ORIC Pharmaceuticals Inc.
Person profile
Roles
Address
Sunnyvale, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Nurix Therapeutics, Inc.
20 May 24
4
Enliven Therapeutics, Inc.
10 Apr 24
3
Enliven Therapeutics, Inc.
10 Apr 24
4
Oric Pharmaceuticals, Inc.
15 Jun 23
4
Nurix Therapeutics, Inc.
4 May 23
4
Oric Pharmaceuticals, Inc.
17 Jun 22
4
Nurix Therapeutics, Inc.
6 May 22
4
CURIS INC
31 Jan 22
4
Oric Pharmaceuticals, Inc.
17 Jun 21
4
Nurix Therapeutics, Inc.
24 May 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 May 24 | NRIX Nurix Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 16.19 | 25,000 | 404.75 k | 25,000 |
8 Apr 24 | ELVN Enliven Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 18.3 | 37,882 | 693.24 k | 37,882 |
14 Jun 23 | ORIC ORIC Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 6.33 | 20,500 | 129.77 k | 20,500 |
4 May 23 | NRIX Nurix Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 9.44 | 25,000 | 236.00 k | 25,000 |